Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Life Sciences - July, 2004
41 articles
- Knobbe Martens Team Wins Judgment Against Another Tyco Unit
- Pfizer Loses Marketing Exclusivity For Diflucan
- ANDA Filing Not Willful Patent Infringement Per Se, Federal Circuit Rules
- Chinese Drug Makers Target Glaxo Drug, Citing Viagra Decision
- Appeals Court Orders FDA To Stay ANDA Approval For Neurontin Generic Capsules
- Judge Grants Summary Judgment For Gen-Probe In Enzo's Patent Suit
- OraSure Sues Schering-Plough For Cryosurgical Patent
- Aventis Loses Second Lovenox Patent Reissuance Bid
- Thermage Sues Syneron Over Patent For Wrinkle Treatment
- Indian Generic Makers Offer 4% Of Turnover In Royalty Under New Patent Regime
- Long-Term Biotech Client Sues Townsend For Malpractice
- Cipla Eyes Generic Challenge To Sanofi-Synthelabo's Plavix
- Mylan Acquires King For $4B In Move Toward Branded Drugs
- AstraZeneca Sues Andrx Over Toprol-XL Patent
- Schick Seeks Injunction Against Gillette's Latest Razor
- Plavix Patent Trial Delayed
- Teva Files Paragraph IV ANDA For Avapro
- European Patent Office Revokes Merck's Fosamax Patent
- Pfizer, Trade Group Protest China's Overturn Of Viagra Patent
- Abbott Settles Suits Over Norvir Amid Calls For Compulsory License
- Inverness Medical Innovations Granted Injunction Against Acon Laboratories
- Dr. Reddy's Files FDA Drugmaster Application For Nexium
- Federal Circuit Rules For Bristol-Myers In Repligen Patent Suit
- Nellcor Says Court Rules In Its Favor In Masimo Patent Suit
- Federal Circuit: Abbott Did Not Infringe Novartis Patent For Human Transplant Drug
- India Eyes Patent Reforms Without Industry Input
- U.S., Israel Deadlocked Over Data Exclusivity Rules
- GlaxoSmithKline To Pay $92m To Settle Suits Over Patent Gaming
- New Zealand Reaffirms Ban On "Methods" Patents
- Xcel Sues Par Pharma Unit Over ANDA For Diastat Generic
- China Overturns Pfizer's Viagra Patent
- Partial Victory For Pfizer In Xalatan Suit Vs. Par
- Mylan Pays $9M To Settle Paclitaxel Patent Suit
- Duke Suit Vs. Elan Targets Competing Patent Filings
- Federal Appeals Court Rejects Hearing On Cox-2 Patent
- House Of Lords To Hear Amgen,TKT Patent Dispute Next Week
- CIBA's Witness Concerns Unfounded: CooperVision
- Court Rules For Pfizer In Accupril Patent Suit
- Federal Judge Dismisses Promega Suit Vs. Hoffman LaRoche, Applera
- Barr Cleared Of Infringing Three Patents In Allegra Case
- Mylan Demands FDA Response To Petition On "Branded Generics"